100% Quality Guarantee
PhD-Level Technical Support
Key Features

CR3022 Biosimilar (SARS-CoV) Antibody (HDBS0013)

SKU HDBS0013
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein SARS
Reactivity Human
Host Species Humanized
Isotype IgG1
€431

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

CR3022 Biosimilar (SARS-CoV) Antibody (HDBS0013)

The Anti-SARS CoV CR3022 Monoclonal Antibody (HDBS0013) is a vital tool for research into the SARS CoV virus, specifically targeting the CR3022 epitope. This antibody, derived from hybridoma cells, is highly specific and sensitive in detecting the SARS CoV virus in samples, making it ideal for use in ELISA and other immunoassay applications.The CR3022 epitope is a key target in studying the SARS CoV virus, as it plays a crucial role in viral entry and infection. By targeting this epitope with the CR3022 monoclonal antibody, researchers can gain valuable insights into the mechanisms of viral infection and develop strategies for therapeutic intervention.

Furthermore, the high specificity and sensitivity of the CR3022 monoclonal antibody make it a valuable tool for the development of diagnostic tests for SARS CoV infection. Its ability to specifically detect the virus in samples makes it a reliable option for screening and monitoring viral infections, contributing to the overall effort in controlling and preventing the spread of SARS CoV.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose